Grant of Share Options

Summary by AI BETAClose X

Candessa AI PLC has granted share options to employees, totaling 4,100,000 ordinary shares, comprising 2,100,000 EMI options with exercise prices ranging from 8.8p to 25p and 2,000,000 unapproved options at 30p, all expiring on 27 October 2031. Following this grant, the company now has 14,675,000 share options outstanding, representing 11.3% of the current issued share capital, with a weighted average exercise price of 37.73p.

Disclaimer*

Candessa AI PLC
29 October 2026
 

29 October 2026

Candessa AI plc

("Candessa AI" or the "Company")

 

Grant of Share Options

 

Candessa AI plc (AIM: CAS), a leading provider of AI-led data infrastructure and machine learning solutions, announces the grant of share options over 4,100,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares”) to certain employees.

Options over 2,100,000 Ordinary Shares were granted under the Company’s Enterprise Management Incentive ("EMI") scheme (the "EMI Options"), and options over 2,000,000 Ordinary Shares were granted as unapproved options outside the scheme (the "Non-Scheme Options").

 

Schedule of EMI Options:

 

 

Position

Date of grant

No. Options granted

Exercise price

Expiry date

Employees (various)

N/A

28 October 2026

2,000,000

50,000

50,000

8.8p

20p

25p

27 October 2031

27 October 2031

27 October 2031

 

 

Schedule of Non-Scheme Options:

 

 

Position

Date of grant

No. Options granted

Exercise price

Expiry date

Employee

N/A

28 October 2026

2,000,000

30p

27 October 2031

 

 

Following the grant of the Options, the Company now has a total of 14,675,000 share options in issue, which represents 11.3% of the current issued share capital, and will represent 10.93% of the enlarged issued share capital following the admission of the new Ordinary Shares pursuant to the Subscription and the Additional Subscription (each as defined in the Company’s announcement made earlier today). The weighted average exercise price of the 14,675,000 options in issue is 37.73p.

 

For further information, please visit www.candessa.com or contact:  

Candessa AI plc

Richard Bernstein (CEO)

 

richard.bernstein@candessa.com

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold

+44 (0) 20 3829 5000

CMC Markets (Joint Broker)

Doug Crippin

+44 (0) 20 3003 8632

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings